×

Merck CEO: We're doing the right studies to make KeyTruda broadly available

2:02 PM ET Thu, 11 May 2017

Merck CEO Kenneth Frazier speaks to CNBC's Meg Tirrell about the FDA's approval of the company's lung cancer treatment KeyTruda and the general fight against cancer.